Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial-Reference-Cited by-同舟云学术

Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial

Published:2016-07-22 Issue:1 Volume:17 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Banerjee Philip J.,Cornelius Victoria R.,Phillips Rachel^ORCID,Lo Jessica W.,Bunce Catey,Kelly Joanna,Murphy Caroline,Edwards Rhiannon Tudor,Robertson Elizabeth L.,Charteris David G.

Funder

Health Technology Assessment Programme

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-016-1445-7

Reference55 articles.

1. Esmaeli B, Elner SG, Schork MA, Elner VM. Visual outcome and ocular survival after penetrating trauma: a clinicopathologic study. Ophthalmology. 1995;102(3):393–400.

2. Negrel AD, Thylefors B. The global impact of eye injuries. Ophthalmic Epidemiol. 1998;5(3):143–69.

3. National Society to Prevent Blindness. Vision problems in the U.S.: data analysis. New York: National Society to Prevent Blindness; 1980. p. 25–6.